CAD 0.04
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 5.91 Million CAD | 556.78% |
2022 | 900.81 Thousand CAD | -28.63% |
2021 | 1.26 Million CAD | -6.73% |
2020 | 1.35 Million CAD | 18.45% |
2019 | 1.14 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 5.59 Million CAD | -4.99% |
2024 Q3 | 3.96 Million CAD | -5.82% |
2024 Q2 | 4.18 Million CAD | -6.46% |
2023 Q2 | 5.92 Million CAD | 574.65% |
2023 Q1 | 878.94 Thousand CAD | -2.43% |
2023 FY | 5.91 Million CAD | 556.78% |
2023 Q4 | 5.91 Million CAD | 3.67% |
2023 Q3 | 5.7 Million CAD | -3.76% |
2022 Q4 | 900.81 Thousand CAD | -2.31% |
2022 Q1 | 1.24 Million CAD | -1.25% |
2022 Q3 | 922.07 Thousand CAD | -24.97% |
2022 FY | 900.81 Thousand CAD | -28.63% |
2022 Q2 | 1.22 Million CAD | -1.41% |
2021 Q3 | 2.26 Million CAD | 15.76% |
2021 Q2 | 1.95 Million CAD | 44.76% |
2021 Q1 | 1.35 Million CAD | -0.19% |
2021 Q4 | 1.26 Million CAD | -44.23% |
2021 FY | 1.26 Million CAD | -6.73% |
2020 Q1 | 5.44 Million CAD | 376.34% |
2020 FY | 1.35 Million CAD | 18.45% |
2020 Q4 | 1.35 Million CAD | -22.72% |
2020 Q3 | 1.75 Million CAD | 4.72% |
2020 Q2 | 1.67 Million CAD | -69.27% |
2019 Q1 | - CAD | 0.0% |
2019 Q3 | 881.5 Thousand CAD | 0.0% |
2019 Q4 | 1.14 Million CAD | 29.59% |
2019 FY | 1.14 Million CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | -913.794% |
Decibel Cannabis Company Inc. | 32.34 Million CAD | 81.71% |
Delivra Health Brands Inc. | 1.78 Million CAD | -231.449% |
Entourage Health Corp. | 5.79 Million CAD | -2.128% |
Lifeist Wellness Inc. | 868.65 Thousand CAD | -581.092% |
Cannara Biotech Inc. | 39.73 Million CAD | 85.112% |
Medicure Inc. | 229 Thousand CAD | -2483.562% |
PharmaCielo Ltd. | 2.55 Million CAD | -131.704% |
Rubicon Organics Inc. | - CAD | -Infinity% |
BioSyent Inc. | 1.03 Million CAD | -470.124% |
Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -14690.893% |